(Q44855240)

6 December 2017

Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas (English)

1 reference

6 December 2017

10

1 reference

6 December 2017

7

Stefano A Pileri

1 reference

6 December 2017

Cecile Meier

1

1 reference

6 December 2017

Sylvia Hoeller

2

1 reference

6 December 2017

Caroline Bourgau

3

1 reference

6 December 2017

Petra Hirschmann

4

1 reference

6 December 2017

Juerg Schwaller

5

1 reference

6 December 2017

Philip Went

6

1 reference

6 December 2017

Andreas Reiter

8

1 reference

6 December 2017

Stephan Dirnhofer

9

1 reference

6 December 2017

9 January 2009

1 reference

6 December 2017

1 reference

6 December 2017

22

1 reference

6 December 2017

3

1 reference

6 December 2017

476-487

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.207

6 December 2017

0 references

cites work

Jak2: normal function and role in hematopoietic disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Chronic idiopathic myelofibrosis (CIMF) resulting from a unique 3;9 translocation disrupting the janus kinase 2 (JAK2) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

The role of Janus kinases in haemopoiesis and haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

JAK/STAT signal transduction: regulators and implication in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Stats: transcriptional control and biological impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

The JAK-STAT pathway: a therapeutic target in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

JAK2 V617F mutation is uncommon in non-Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Receiver operating characteristic curve inference from a sample with a limit of detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

The role of cytokines in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

The STAT3 oncogene as a predictive marker of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

7 January 2021

Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

7 January 2021

Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

7 January 2021

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

7 January 2021

Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.207

7 January 2021

10.1038/MODPATHOL.2008.207

Identifiers

DOI

1 reference

6 December 2017

1 reference